Cipla reported INR7.89B in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Cipla CIPLA:IN INR 7.89B 1.03B
Dr.Reddys Laboratories DRRD:IN INR 11.14B 748M
Sun Pharmaceuticals SUNP:IN INR 22.62B 2.01B
UPL UPLL:IN INR 8.14B 630M